Your browser doesn't support javascript.
loading
A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes.
Jang, Jun Ho; Harada, Hironori; Shibayama, Hirohiko; Shimazaki, Ryutaro; Kim, Hyeoung-Joon; Sawada, Kenichi; Mitani, Kinuko.
Afiliação
  • Jang JH; Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. smcjunhojang@gmail.com.
  • Harada H; Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Shibayama H; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
  • Shimazaki R; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kim HJ; R&D Division, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
  • Sawada K; Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea.
  • Mitani K; Akita University, Akita, Japan.
Int J Hematol ; 102(4): 401-12, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26323997

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transfusão de Eritrócitos / Darbepoetina alfa Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Int J Hematol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transfusão de Eritrócitos / Darbepoetina alfa Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Int J Hematol Ano de publicação: 2015 Tipo de documento: Article